Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Belch, J; Carlizza, A; Carpentier, PH; Constans, J; Khan, F; Wautrecht, JC; Visona, A; Heiss, C; Brodeman, M; Pécsvárady, Z; Roztocil, K; Colgan, MP; Vasic, D; Gottsäter, A; Amann-Vesti, B; Chraim, A; Poredoš, P; Olinic, DM; Madaric, J; Nikol, S; Herrick, AL; Sprynger, M; Klein-Weigel, P; Hafner, F; Staub, D; Zeman, Z.
ESVM guidelines - the diagnosis and management of Raynaud's phenomenon.
Vasa. 2017; 46(6):413-423
Doi: 10.1024/0301-1526/a000661
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
-
Hafner Franz
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
Regarding the clinical diagnosis of Raynaud's phenomenon and its associated conditions, investigations and treatment are substantial, and yet no international consensus has been published regarding the medical management of patients presenting with this condition. Most knowledge on this topic derives from epidemiological surveys and observational studies; few randomized studies are available, almost all relating to drug treatment, and thus these guidelines were developed as an expert consensus document to aid in the diagnosis and management of Raynaud's phenomenon. This consensus document starts with a clarification about the definition and terminology of Raynaud's phenomenon and covers the differential and aetiological diagnoses as well as the symptomatic treatment.
- Find related publications in this database (using NLM MeSH Indexing)
-
Consensus -
-
Humans -
-
Predictive Value of Tests -
-
Raynaud Disease - classification
-
Raynaud Disease - diagnosis
-
Raynaud Disease - epidemiology
-
Raynaud Disease - therapy
-
Risk Factors -
-
Terminology as Topic -
-
Treatment Outcome -
- Find related publications in this database (Keywords)
-
Raynaud's
-
systemic sclerosis
-
vasospasm
-
hand arm vibration